These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 14500668)

  • 1. Strong cytosine-guanosine-independent immunostimulation in humans and other primates by synthetic oligodeoxynucleotides with PyNTTTTGT motifs.
    Elias F; Flo J; Lopez RA; Zorzopulos J; Montaner A; Rodriguez JM
    J Immunol; 2003 Oct; 171(7):3697-704. PubMed ID: 14500668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunostimulatory PyNTTTTGT oligodeoxynucleotides: structural properties and refinement of the active motif.
    Rodriguez JM; Elías F; Fló J; López RA; Zorzopulos J; Montaner AD
    Oligonucleotides; 2006; 16(3):275-85. PubMed ID: 16978090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The arthritogenic and immunostimulatory properties of phosphorothioate oligodeoxynucleotides rely on synergy between the activities of the nuclease-resistant backbone and CpG motifs.
    Bjersing JL; Eriksson K; Tarkowski A; Collins LV
    Inflammation; 2004 Feb; 28(1):39-51. PubMed ID: 15072229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo.
    Hartmann G; Weeratna RD; Ballas ZK; Payette P; Blackwell S; Suparto I; Rasmussen WL; Waldschmidt M; Sajuthi D; Purcell RH; Davis HL; Krieg AM
    J Immunol; 2000 Feb; 164(3):1617-24. PubMed ID: 10640783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of thymocyte proliferation by phosphorothioate DNA oligonucleotides.
    Mannon RB; Nataraj C; Pisetsky DS
    Cell Immunol; 2000 Apr; 201(1):14-21. PubMed ID: 10805969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of marginal zone B cells from lupus mice with type A(D) CpG-oligodeoxynucleotides.
    Brummel R; Lenert P
    J Immunol; 2005 Feb; 174(4):2429-34. PubMed ID: 15699180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly immunostimulatory CpG-free oligodeoxynucleotides for activation of human leukocytes.
    Vollmer J; Janosch A; Laucht M; Ballas ZK; Schetter C; Krieg AM
    Antisense Nucleic Acid Drug Dev; 2002 Jun; 12(3):165-75. PubMed ID: 12162699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PyNTTTTGT and CpG immunostimulatory oligonucleotides: effect on granulocyte/monocyte colony-stimulating factor (GM-CSF) secretion by human CD56+ (NK and NKT) cells.
    Rodriguez JM; Marchicio J; López M; Ziblat A; Elias F; Fló J; López RA; Horn D; Zorzopulos J; Montaner AD
    PLoS One; 2015; 10(2):e0117484. PubMed ID: 25706946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hierarchical recognition of CpG motifs expressed by immunostimulatory oligodeoxynucleotides.
    Klinman DM; Currie D
    Clin Exp Immunol; 2003 Aug; 133(2):227-32. PubMed ID: 12869028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells.
    Decker T; Schneller F; Sparwasser T; Tretter T; Lipford GB; Wagner H; Peschel C
    Blood; 2000 Feb; 95(3):999-1006. PubMed ID: 10648415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole blood cultures to assess the immunostimulatory activities of CpG oligodeoxynucleotides.
    Pichyangkul S; Yongvanitchit K; Kum-arb U; Krieg AM; Heppner DG; Walsh DS
    J Immunol Methods; 2001 Jan; 247(1-2):83-94. PubMed ID: 11150539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of oligodeoxyribonucleotides that induce interferon (IFN)-alpha in the pig and the phenotype of the IFN-alpha producing cells.
    Domeika K; Magnusson M; Eloranta ML; Fuxler L; Alm GV; Fossum C
    Vet Immunol Immunopathol; 2004 Sep; 101(1-2):87-102. PubMed ID: 15261695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human peripheral blood cells differentially recognize and respond to two distinct CPG motifs.
    Verthelyi D; Ishii KJ; Gursel M; Takeshita F; Klinman DM
    J Immunol; 2001 Feb; 166(4):2372-7. PubMed ID: 11160295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PyNTTTTGT prototype oligonucleotide IMT504, a novel effective adjuvant of the FMDV DNA vaccine.
    Zhao G; Jin H; Li J; Su B; Du X; Kang Y; Wang X; Wang B
    Viral Immunol; 2009 Apr; 22(2):131-8. PubMed ID: 19327000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligodeoxynucleotides without CpG motifs work as adjuvant for the induction of Th2 differentiation in a sequence-independent manner.
    Sano K; Shirota H; Terui T; Hattori T; Tamura G
    J Immunol; 2003 Mar; 170(5):2367-73. PubMed ID: 12594259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells.
    Moseman EA; Liang X; Dawson AJ; Panoskaltsis-Mortari A; Krieg AM; Liu YJ; Blazar BR; Chen W
    J Immunol; 2004 Oct; 173(7):4433-42. PubMed ID: 15383574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a hexameric deoxyriboguanosine run conjugation into CpG oligodeoxynucleotides on their immunostimulatory potentials.
    Lee SW; Song MK; Baek KH; Park Y; Kim JK; Lee CH; Cheong HK; Cheong C; Sung YC
    J Immunol; 2000 Oct; 165(7):3631-9. PubMed ID: 11034366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD40-dependent and -independent activation of human tonsil B cells by CpG oligodeoxynucleotides.
    Gantner F; Hermann P; Nakashima K; Matsukawa S; Sakai K; Bacon KB
    Eur J Immunol; 2003 Jun; 33(6):1576-85. PubMed ID: 12778475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery system.
    Hanagata N
    Int J Nanomedicine; 2012; 7():2181-95. PubMed ID: 22619554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclease-resistant immunostimulatory phosphodiester CpG oligodeoxynucleotides as human Toll-like receptor 9 agonists.
    Meng W; Yamazaki T; Nishida Y; Hanagata N
    BMC Biotechnol; 2011 Sep; 11():88. PubMed ID: 21943407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.